These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 393630)
1. Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis. Wilkinson BJ; Sisson SP; Kim Y; Peterson PK Infect Immun; 1979 Dec; 26(3):1159-63. PubMed ID: 393630 [TBL] [Abstract][Full Text] [Related]
2. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement. Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223 [TBL] [Abstract][Full Text] [Related]
3. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci. Peterson PK; Kim Y; Wilkinson BJ; Schmeling D; Michael AF; Quie PG Infect Immun; 1978 Jun; 20(3):770-5. PubMed ID: 352958 [TBL] [Abstract][Full Text] [Related]
4. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Quie PG Infect Immun; 1978 Mar; 19(3):943-9. PubMed ID: 640738 [TBL] [Abstract][Full Text] [Related]
5. Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers. Wilkinson BJ; Peterson PK; Quie PG Infect Immun; 1979 Feb; 23(2):502-8. PubMed ID: 422250 [TBL] [Abstract][Full Text] [Related]
6. Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis. Cunnion KM; Zhang HM; Frank MM Infect Immun; 2003 Feb; 71(2):656-62. PubMed ID: 12540542 [TBL] [Abstract][Full Text] [Related]
7. The key role of peptidoglycan in the opsonization of Staphylococcus aureus. Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Douglas SD; Quie PG; Verhoef J J Clin Invest; 1978 Mar; 61(3):597-609. PubMed ID: 641141 [TBL] [Abstract][Full Text] [Related]
8. Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains. Verbrugh HA; van Dijk WC; van Erne ME; Peters R; Peterson PK; Verhoef J Infect Immun; 1979 Dec; 26(3):808-14. PubMed ID: 393633 [TBL] [Abstract][Full Text] [Related]
9. Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule. Brown EJ; Joiner KA; Cole RM; Berger M Infect Immun; 1983 Jan; 39(1):403-9. PubMed ID: 6822421 [TBL] [Abstract][Full Text] [Related]
10. Specific serum Ig recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against Staphylococcus aureus. Jung DJ; An JH; Kurokawa K; Jung YC; Kim MJ; Aoyagi Y; Matsushita M; Takahashi S; Lee HS; Takahashi K; Lee BL J Immunol; 2012 Nov; 189(10):4951-9. PubMed ID: 23071283 [TBL] [Abstract][Full Text] [Related]
11. Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Xu S; Arbeit RD; Lee JC Infect Immun; 1992 Apr; 60(4):1358-62. PubMed ID: 1548061 [TBL] [Abstract][Full Text] [Related]
12. Opsonic recognition of staphylococci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies. Verbrugh HA; van Dijk WC; Peters R; van Erne ME; Daha MR; Peterson PK; Verhoef J J Immunol; 1980 Mar; 124(3):1167-73. PubMed ID: 7358981 [No Abstract] [Full Text] [Related]
14. Protein A effect on alternative pathway complement activation and opsonization of Staphylococcus aureus. Spika JS; Verbrugh HA; Verhoef J Infect Immun; 1981 Nov; 34(2):455-60. PubMed ID: 7309234 [TBL] [Abstract][Full Text] [Related]
15. Surface Glycopolymers Are Crucial for In Vitro Anti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus. Lee JH; Kim NH; Winstel V; Kurokawa K; Larsen J; An JH; Khan A; Seong MY; Lee MJ; Andersen PS; Peschel A; Lee BL Infect Immun; 2015 Nov; 83(11):4247-55. PubMed ID: 26283333 [TBL] [Abstract][Full Text] [Related]
16. Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus. Veringa EM; Verhoef J Chemotherapy; 1987; 33(4):243-9. PubMed ID: 3608624 [TBL] [Abstract][Full Text] [Related]
17. Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Cunnion KM; Lee JC; Frank MM Infect Immun; 2001 Nov; 69(11):6796-803. PubMed ID: 11598052 [TBL] [Abstract][Full Text] [Related]
18. Suppression of phagocytosis and chemotaxis by cell wall components of Staphylococcus aureus. Musher DM; Verbrugh HA; Verhoef J J Immunol; 1981 Jul; 127(1):84-8. PubMed ID: 7240751 [TBL] [Abstract][Full Text] [Related]
19. Binding of human immunoglobulin G to protein A in encapsulated Staphylococcus aureus. King BF; Wilkinson BJ Infect Immun; 1981 Sep; 33(3):666-72. PubMed ID: 7287175 [TBL] [Abstract][Full Text] [Related]
20. Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages. Verbrugh HA; Peterson PK; Smith DE; Nguyen BY; Hoidal JR; Wilkinson BJ; Verhoef J; Furcht LT Infect Immun; 1981 Sep; 33(3):811-9. PubMed ID: 7287184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]